SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.28
+1.59%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $5.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.02
- EPS estimate
- -$0.30
- Revenue actual
- $6.4M
- Revenue estimate
- $5.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.0%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.30 | $0.02 | Beat 106.67% | $6.4M |
| Jun 16, 2026 | -$0.24 | -$0.09 | Beat 62.50% | $5.6M |
| Aug 7, 2025 | -$0.51 | -$0.37 | Beat 27.45% | $4.0M |
| Jun 17, 2025 | -$0.73 | -$0.15 | Beat 79.45% | $3.8M |
| Feb 5, 2025 | -$0.80 | -$0.59 | Beat 26.25% | $3.6M |
| Nov 7, 2024 | -$1.00 | -$0.59 | Beat 41.00% | $3.6M |
| Jun 17, 2024 | -$3.41 | -$1.40 | Beat 58.92% | $3.4M |
| Feb 8, 2024 | -$0.21 | -$1.20 | Miss -471.43% | $3.1M |
| Nov 13, 2023 | -$0.24 | -$4.00 | Miss -1566.67% | $2.7M |
| Aug 10, 2023 | -$2.40 | -$5.80 | Miss -141.67% | $3.4M |
| Jun 21, 2023 | — | -$4.60 | — | $3.0M |
| Feb 14, 2023 | — | -$10 | — | $2.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026